BioLife Solutions Inc (BLFS)
Debt-to-equity ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 4,997 | 17,561 | 23,793 | 6,353 | 655 |
Total stockholders’ equity | US$ in thousands | 348,909 | 337,663 | 364,188 | 478,047 | 204,429 |
Debt-to-equity ratio | 0.01 | 0.05 | 0.07 | 0.01 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $4,997K ÷ $348,909K
= 0.01
Based on the data provided, BioLife Solutions Inc's debt-to-equity ratio has shown a consistent and relatively low trend over the past five years. The ratio remained at 0.00 in December 31, 2020, increased slightly to 0.01 in December 31, 2021, and then saw a notable uptick to 0.07 in December 31, 2022. However, the ratio decreased to 0.05 in December 31, 2023, and dropped back to 0.01 by December 31, 2024.
Overall, the company's debt-to-equity ratio indicates that BioLife Solutions Inc has been maintaining a conservative capital structure with a low level of debt relative to its equity over the specified period. This implies that the company has been relying more on equity financing rather than debt, which may signify lower financial risk and potentially greater stability for the business.
Peer comparison
Dec 31, 2024